High-dose statins in acute coronary syndromes - Not just lipid levels

被引：86

作者：

Nissen, SE ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 11期

关键词：

D O I：

10.1001/jama.292.11.1365

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1365 / 1367

页数：3

共 23 条

[1] Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial [J].

Ballantyne, CM ;

Houri, J ;

Notarbartolo, A ;

Melani, L ;

Lipka, LJ ;

Suresh, R ;

Sun, S ;

LeBeaut, AP ;

Sager, PT ;

Veltri, EP .

CIRCULATION, 2003, 107 (19) :2409-2415

[2] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[3]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[4] The efficacy and six-week tolerability of Simvastatin 80 and 160 mg/day [J].

Davidson, MH ;

Stein, EA ;

Dujovne, CA ;

Hunninghake, DB ;

Weiss, SR ;

Knopp, RH ;

Illingworth, DR ;

Mitchel, YB ;

Melino, MR ;

Zupkis, RV ;

Dobrinska, MR ;

Amin, RD ;

Tobert, JA .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01) :38-42

[5]

Davidson MH, 2000, NUTR METAB CARDIOVAS, V10, P253

[6] Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].

de Lemos, JA ;

Blazing, MA ;

Wiviott, SD ;

Lewis, EF ;

Fox, KAA ;

White, HD ;

Rouleau, JL ;

Pedersen, TR ;

Gardner, LH ;

Mukherjee, R ;

Ramsey, KE ;

Palmisano, J ;

Bilheimer, DW ;

Pfeffer, MA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316

[7] High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study [J].

Kinlay, S ;

Schwartz, GG ;

Olsson, AG ;

Rifai, N ;

Leslie, SJ ;

Sasiela, WJ ;

Szarek, M ;

Libby, P ;

Ganz, P .

CIRCULATION, 2003, 108 (13) :1560-1566

[8]

MacMahon M, 2000, NUTR METAB CARDIOVAS, V10, P195

[9] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[10] Publication bias in editorial decision making [J].

Olson, CM ;

Rennie, D ;

Cook, D ;

Dickersin, K ;

Flanagin, A ;

Hogan, JW ;

Zhu, Q ;

Reiling, J ;

Pace, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21) :2825-2828

← 1 2 3 →